UPMC- RxAnte, a leading provider of solutions that improve the use of prescription medications, announced today that it has received a growth equity investment from UPMC Enterprises. Under the terms of the transaction closed on Sept. 30, Millennium Health sold its entire interest in RxAnte, which will continue to operate as an independent company, led by its existing management team.
Recent Posts
A Year in Review: A comprehensive look at UPMC Enterprises 2020
Over the last year, UPMC Enterprises, our portfolio companies, and select partners have all supported UPMC’s mission of Life Changing Medicine. In the booklet below, we have compiled highlights from a truly unique year and recognize the team members and projects that have enabled our success.
Read More →
Writing a Fully Unit Testable Android App: The journey begins at the start of your project
Even as recently as API 30, the platform continues to evolve in this unfortunate direction, …
Read More →
Machine Learning and Structural Bias in Health Care
In November 2020, the Center for Connected Medicine (CCM) convened a group of experts in …
Read More →